You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Express Scripts
Johnson and Johnson
Harvard Business School
Mallinckrodt

Last Updated: May 13, 2021

DrugPatentWatch Database Preview

Valeant Pharms North Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for VALEANT PHARMS NORTH, and what generic alternatives to VALEANT PHARMS NORTH drugs are available?

VALEANT PHARMS NORTH has sixteen approved drugs.

There is one US patent protecting VALEANT PHARMS NORTH drugs.

Summary for Valeant Pharms North
US Patents:1
Tradenames:13
Ingredients:12
NDAs:16

Drugs and US Patents for Valeant Pharms North

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Pharms North DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 075116-003 Dec 23, 1999 AB3 RX No No   Get Started for $10   Get Started for $10
Valeant Pharms North DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 075116-004 Dec 23, 1999 AB3 RX No No   Get Started for $10   Get Started for $10
Valeant Pharms North NORITATE metronidazole CREAM;TOPICAL 020743-001 Sep 26, 1997 RX Yes Yes   Get Started for $10   Get Started for $10
Valeant Pharms North PEPCID famotidine TABLET;ORAL 019462-001 Oct 15, 1986 DISCN Yes No   Get Started for $10   Get Started for $10
Valeant Pharms North DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 075116-001 Dec 23, 1999 AB3 RX No No   Get Started for $10   Get Started for $10
Valeant Pharms North SECONAL SODIUM secobarbital sodium CAPSULE;ORAL 086101-002 Oct 3, 1983 DISCN No No   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Valeant Pharms North

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharms North RENOVA tretinoin CREAM;TOPICAL 019963-001 Dec 29, 1995 4,877,805   Get Started for $10
Valeant Pharms North RENOVA tretinoin CREAM;TOPICAL 021108-001 Aug 31, 2000 6,531,141   Get Started for $10
Valeant Pharms North CARAC fluorouracil CREAM;TOPICAL 020985-001 Oct 27, 2000 4,690,825   Get Started for $10
Valeant Pharms North RETIN-A tretinoin CREAM;TOPICAL 017340-001 Approved Prior to Jan 1, 1982 3,906,108   Get Started for $10
Valeant Pharms North PEPCID famotidine TABLET;ORAL 019462-001 Oct 15, 1986 4,283,408*PED   Get Started for $10
Valeant Pharms North PEPCID famotidine TABLET;ORAL 019462-002 Oct 15, 1986 4,283,408*PED   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for VALEANT PHARMS NORTH drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Cream 0.5% ➤ Subscribe 2011-07-29
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Medtronic
Mallinckrodt
Harvard Business School
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.